Skip to main content
  • TAVR 'Paradox' as Acurate neo Shines in Mid-Term Outcomes

    Device veers from typical TAVR innovation path but with 'favorable' results

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details